Mumbai News Network Latest News
Showing posts with label
Takeda
.
Show all posts
Showing posts with label
Takeda
.
Show all posts
Thursday, 9 July 2020
Takeda strengthens patient offering in India via availability of Vedolizumab (Kynteles®)
›
innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn'...
Wednesday, 8 July 2020
Takeda strengthens patient offering in India via availability of Vedolizumab (Kynteles®)
›
· Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Coliti...
Saturday, 7 March 2020
Takeda initiates Development of a Plasma-Derived Therapy for COVID-19
›
Anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) being developed to treat infected, high-risk individuals with COVID-19 Exploring...
Tuesday, 25 February 2020
Takeda appoints new Area Head for India, C.I.S., Middle East, Turkey, and Africa
›
Mahender Nayak will continue to increase patient access to Takeda’s portfolio of highly innovative medicines Proven leader with mo...
›
Home
View web version
